Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 2146

Accelerated approval brings Pfizer's BRAF inhibitor to first-line patients

$
0
0
Pfizer scored an accelerated approval Friday to bring its BRAF inhibitor to first-line colorectal cancer patients. Braftovi was approved in combination with cetuximab, also known as Eli Lilly’s Erbitux, and a ...

Viewing all articles
Browse latest Browse all 2146

Trending Articles